Introduction {#s1}
============

The prevalence of diabetes is soaring up in the recent decades. The global number of diabetes patients was 173 million in 2002 and will increase to 350 million by 2030. As a group of metabolic diseases characterized with high blood sugar, most diabetes is caused by either a lack of insulin for type 1 diabetes (T1D) or a blockage in the insulin signaling pathway for type 2 diabetes (T2D). The classical symptoms of diabetes consist of polyuria, polydipsia, polyphagia and weight loss. Diabetes also causes damages to blood vessels and capillaries that may eventually lead to coronary heart diseases and blindness, respectively.

T1D and T2D are two major types of diabetes [@pone.0070301-WHO1]. Microbial exposures and sex hormones together with lifestyle factors have been shown to be important to the development of this complex disease [@pone.0070301-Markle1], [@pone.0070301-Ashcroft1]. Besides environmental factors, twin studies have demonstrated a strong heritability for diabetes [@pone.0070301-Hyttinen1], [@pone.0070301-Jenkins1] and insulin related phenotypes [@pone.0070301-Wang1]--[@pone.0070301-BeckNielsen1]. A handful of candidate genes have been found for both the risk and complex traits of the two major types of diabetes [@pone.0070301-Ashcroft1], [@pone.0070301-Huyghe1]--[@pone.0070301-Cho1].

T1D is an autoimmune disease. Little or no insulin is produced by pancreatic beta cells that may be mistakenly attacked after an infection or some other triggers. The present meta-analyses of T1D focus on four immunomodulatory genes including *IL2RA*, *NLRP1*, *IL12B* and *CLEC16A. IL2RA* gene encodes the α-chain of IL-2 receptor (IL-2R) complex which acts as an important modulator to regulate T-cell immune response [@pone.0070301-Kim1]. *NLRP1* gene encodes a member of the Ced-4 family of apoptosis proteins that can stimulate innate immunity [@pone.0070301-Tschopp1]. *IL12B* gene encodes a subunit of an important immunomodulatory cytokine, IL-12. IL-12 induces production from NK and T cells of interferon γ (IFN-γ) which favors Th1 cell differentiation [@pone.0070301-Trinchieri1]. *CLEC16A* encodes C-type lectin domain family 16 (CLEC16A) protein highly expressed on B-lymphocytes, natural killer (NK) and dendritic cells [@pone.0070301-Zoledziewska1].

The impairment of insulin signaling in T2D is complex. Insulin signaling is involved in both glucose and lipid metabolism. In the present meta-analyses of T2D, we selected 2 genes in glucose metabolism (*SLC2A10* and *CASQ1*), 2 genes in lipid metabolism (*APOA5* and *KLF11*), and 2 genes in signal transduction (*ATF6* and *GNB3*). *SLC2A10* gene encodes a member of the facilitative glucose transporter family with an effect on maintaining glucose homeostasis. *CASQ1* gene encodes acidic glycoprotein calsequestrin 1 (CASQ1) that is a calcium storage protein and calcium is considered to regulate the expression of the insulin-responsive glucose transporter GLUT4 [@pone.0070301-Lanner1]. *APOA5* is located on human chromosome 11q23, in the APOA1/APOC3/APOA4 gene cluster [@pone.0070301-Pennacchio1]. *KLF11* encodes Kruppel-like factor 11 with the function of regulating hepatic lipid metabolism [@pone.0070301-Zhang1]. *ATF6* encodes UPR transducer unfolded protein that is related to the endoplasmic reticulum stress in the β-cell pathogenesis of type 2 diabetes [@pone.0070301-Back1]. *GNB3* encodes the β3 subunit of hetero-trimeric G proteins in insulin signaling [@pone.0070301-Chang1].

Associations between single-nucleotide polymorphisms (SNPs) of the above 10 genes and diabetes (including T1D and T2D) have been reported in different ethnic populations [@pone.0070301-Zoledziewska1], [@pone.0070301-Fichna1]--[@pone.0070301-Nistico1]. Here we performed a series of meta-analyses for these SNPs whose allelic frequencies are often substantially different among multiple ethnic populations. The goal of our study is to evaluate the overall contribution of these SNPs to diabetes susceptibility in combined populations using a meta-analysis approach.

Materials and Methods {#s2}
=====================

Search Strategy and Study Selection {#s2a}
-----------------------------------

An initial search was performed through online databases including PubMed, Embase, SpingerLink, Web of Science, Chinese National Knowledge Infrastructure (CNKI), and Wanfang. The keywords comprise the terms including "diabetes" together with "SNP" or "polymorphism" or "variants" or "mutation". The selection of studies in our meta-analysis was abided by the criteria as follows: (1) case-control studies; (2) selected studies have sufficient data to calculate ORs with the corresponding 95% CIs; (3) every polymorphism has at least 3 independent datasets from the retrieved articles; (4) selected polymorphisms have not been addressed in previous meta-analysis of diabetes. Finally, the current meta-analysis involved a total of 10 genetic variants comprising *NLRP1* rs12150220, *IL2RA* rs11594656, *CLEC16A* rs725613,*APOA5* −1131T/C, *SLC2A10* rs2335491, *ATF6* rs2070150, *KLF11* rs35927125, *CASQ1* rs2275703, *GNB3* C825T, and *IL12B* 1188A/C.

Statistical Analysis {#s2b}
--------------------

All the analyses were performed in Review Manager (version 5.0, The Cochrance Collaboration [@pone.0070301-Jiang1]). The combined ORs and the corresponding 95% CIs were calculated and demonstrated in the forest plots using the fixed or the random effects model. Heterogeneity was measured in our meta-analysis using Cochran's Q and the inconsistency index (I^2^) statistic [@pone.0070301-Coory1]. Funnel plots were used to detect whether there were obvious publication bias among the involved studies. An I^2^ value of equal to or greater than 50% indicates a substantial heterogeneity among the studies in the meta-analysis that used a random-effect model for the analysis. For I^2^ value less than 50%, a fixed-effect model will be applied for the meta-analysis. The combined ORs and the corresponding 95% CIs were calculated using the fixed-effect model or the random-effect model if I^2^ is less than 50%. P values less than 0.05 were considered to be significant.

Results {#s3}
=======

As shown in [Figure 1](#pone-0070301-g001){ref-type="fig"}, our initial search for the genetic studies of diabetes retrieved 6,452 articles from PubMed, Embase, Web of Science, CNKI and Wanfang from 2000 to 2012. Among them, 4,021 studies were involved with genes reported in previous meta-analyses and thus discarded for further analysis. A total of 504 articles were again filtered out because they failed to accumulate at least three independent genotypic datasets for the same genetic variants. Among the rest 1,927 studies, 1,882 studies with unconcerned SNPs were removed. At last, there were 42 case-control studies from 37 articles (including 35 articles in English and 2 in Chinese) for the current meta-analyses. There were four SNPs of T1D ([Table 1](#pone-0070301-t001){ref-type="table"}) and six SNPs of T2D ([Table 2](#pone-0070301-t002){ref-type="table"}) involved in our present study.

![Flow diagram of selecting studies for meta-analysis.](pone.0070301.g001){#pone-0070301-g001}

10.1371/journal.pone.0070301.t001

###### Characteristics of individual T1D studies in the meta-analyses.

![](pone.0070301.t001){#pone-0070301-t001-1}

  Gene            SNP       Year         Author         Ethnic Group   Case/Control (n)   Allele 1 (Case/Control)   Allele 2 (Case/Control)
  ----------- ------------ ------ -------------------- -------------- ------------------ ------------------------- -------------------------
  *IL2RA*      rs11594656                                                                            T                         A
                            2007   Christopher E Lowe    Caucasian        2874/2484              4482/3726                 1266/1242
                            2007   Christopher E Lowe    Caucasian        5259/6809             8199/10248                 2319/3370
                            2008    Deborah J Smyth      Caucasian        8064/9339             12548/14083                3580/4595
                            2009     Eiji Kawasaki        Japanese         881/606               1715/1175                   47/37
                            2012       M. Fichna         Caucasian         445/671                701/994                   189/348
  *NLRP1*      rs12150220                                                                            T                         A
                            2009       NF Magitta        Caucasian        1067/3177              929/2987                  1205/3367
                            2010      A. PONTILLO        Brazilian         196/192                248/255                   144/129
                            2011   Magdalena Zurawek     Caucasian         221/254                230/270                   212/238
  *IL12B*       1188 A/C                                                                             A                         C
                            2002    Lorenza Nistico      Caucasian         470/544                662/787                   278/301
                            2002      RM McCormack       Caucasian         120/330                194/533                   46/127
                            2005    José L. Santiago     Caucasian         300/516                453/773                   147/259
                            2010      A.E.Altinova         Turks            91/87                 133/120                    49/54
  *CLEC16A*     rs725613                                                                             A                         C
                            2007    Hakon Hakonarson     Caucasian         561/1143              785/1395                   337/891
                            2009     M Zoledziewska      Caucasian        1037/1706              969/1473                  1105/1939
                            2009      Xiao pan Wu         Chinese          205/422                352/643                   58/201

10.1371/journal.pone.0070301.t002

###### Characteristics of individual T2D studies in the meta-analyses.

![](pone.0070301.t002){#pone-0070301-t002-2}

  Gene            SNP       Year        Author         Ethnic Group   Case/Control (n)   Allele 1 (Case/Control)   Allele 2 (Case/Control)
  ----------- ------------ ------ ------------------- -------------- ------------------ ------------------------- -------------------------
  *APOA5*      −1131 T/C                                                                            T                         C
                            2005     Sheng kai Yan       Chinese          172/155                231/224                   113/86
                            2006     P. J. Talmud       Caucasian         142/2438              273/4401                   11/295
                            2007    Guang hua Zhai       Chinese           71/152                81/214                     61/90
                            2008      Xue feng Li        Chinese          256/340                322/468                   190/212
                            2008       Yan Qiao          Chinese          154/206                222/313                    86/99
  *SLC2A10*    rs2235491                                                                            G                         A
                            2005    Karen L. Mohlke     Caucasian         784/401               1476/746                    92/56
                            2005   Jennifer L Bento     Caucasian         296/305                568/592                    24/18
                            2006       W. H. Lin         Chinese          375/377                691/683                    59/71
  *ATF6*       rs2070150                                                                            C                         G
                            2006    Farook Thameem     Pima Indian        561/399                913/626                   209/172
                            2007   Steven J. R. Meex    Caucasian         367/377                670/693                    64/61
                            2007    Winston S. Chu      Caucasian         191/188                364/350                    18/26
                            2011       Cheng Hu          Chinese         1892/1808              1181/1088                 2603/2528
  *KLF11*      rs35927125                                                                           A                         G
                            2005    Bernadette Neve     Caucasian         313/313                562/517                   64/109
                            2006    Jose C. Florez      Caucasian         469/468                850/854                    88/82
                            2006    Jose C. Florez      Caucasian         504/503                906/910                   102/96
                            2006    Jose C. Florez       Canadian         111/109                195/188                    27/30
                            2006    Jose C. Florez      Caucasian        1207/1198              2129/2103                  285/293
                            2006    Jose C. Florez      Caucasian         1000/997              1789/1779                  211/215
                            2008     T. Tanahashi        Japanese         925/893               1850/1786                    0/0
                            2008       Lijun Ma        Pima Indian       1455/1816              2780/3457                  130/175
  *CASQ1*      rs2275703                                                                            A                         C
                            2004        Mao Fu          Caucasian         145/358                90/305                    200/411
                            2004   Swapan Kumar Das     Caucasian         190/119                205/117                   175/121
                            2007     Thomas Sparsø      Caucasian        1391/4575              1452/4841                 1330/4309
  *GNB3*         rs5443                                                                             C                         T
                            2005    Jawad G. Kiani         Arab           256/254                178/246                   334/262
                            2006      G. Andersen       Caucasian        1358/4723              1855/6574                 861/2872
                            2007    Tetsuo Hayakawa      Japanese         427/388                445/338                   409/388
                            2008     Makoto Daimon       Japanese         230/2576              259/2740                  201/2712

No evidence of statistical heterogeneity was observed for 7 SNPs ([Figures 2](#pone-0070301-g002){ref-type="fig"} and [3](#pone-0070301-g003){ref-type="fig"}, and [Table 3](#pone-0070301-t003){ref-type="table"}), including rs11594656 of *IL2RA* gene (I^2^ = 0%), rs12150220 of *NLRP1* gene (I^2^ = 0%), 1188A/C of *IL12B* gene (I^2^ = 0%), −1131T/C of *APOA5* gene (I^2^ = 1%), rs2335491 of *SLC2A10* gene (I^2^ = 0%), rs2070150 of *ATF6* (I^2^ = 0%), and rs35927125 of *KLF11* gene (I^2^ = 7%). No visual bias was showed in the meta-analyses of these 7 SNPs ([Figure 4](#pone-0070301-g004){ref-type="fig"} and [Table 3](#pone-0070301-t003){ref-type="table"}). Our data also demonstrated a significant heterogeneity of the rest 3 SNPs that comprise rs725613 of *CLEC16A* gene (I^2^ = 69%), rs2275703 of *CASQ1* gene (I^2^ = 65%), and C825T of *GNB3* gene (I^2^ = 82%). Therefore random-effect tests were applied for the meta-analyses of the above 3 SNPs. Their funnel plots were demonstrated in [Figure 4](#pone-0070301-g004){ref-type="fig"} and no visual bias was observed for the 3 meta-analyses.

![Forest plots of the association studies between four SNPs and T1D.](pone.0070301.g002){#pone-0070301-g002}

![Forest plots of the association studies between six SNPs and T2D.](pone.0070301.g003){#pone-0070301-g003}

![Funnel plots of the studies involved in the 10 meta-analyses.](pone.0070301.g004){#pone-0070301-g004}
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###### Additional characteristics of individual T1D and T2D studies in the meta-analyses.

![](pone.0070301.t003){#pone-0070301-t003-3}

  T1D          Gene         SNP             Model            Heterogeneity index       P values
  --------- ----------- ------------ -------------------- ------------------------- --------------
              *IL2RA*    rs11594656   Fixed effectmodel              0%               \<0.00001
              *NLRP1*    rs12150220   Fixed effectmodel              0%                  0.04
              *IL12B*     1188 A/C    Fixed effectmodel              0%                  0.86
             *CLEC16A*    rs725613    Random effectmodel             69%                 0.01
  **T2D**    **Gene**     **SNP**         **Model**        **Heterogeneity index**   **P values**
              *APOA5*    −1131 T/C    Fixed effectmodel              1%                  0.03
             *SLC2A10*   rs2235491    Fixed effectmodel              0%                  0.48
              *ATF6*     rs2070150    Fixed effectmodel              0%                  0.26
              *KLF11*    rs35927125   Fixed effectmodel              7%                  0.27
              *CASQ1*    rs2275703    Random effectmodel             65%                 0.53
              *GNB3*       rs5443     Random effectmodel             82%                 0.82

Meta-analysis of rs12150220 of *NLRP1* gene was involved with 3 studies [@pone.0070301-Zurawek1], [@pone.0070301-Pontillo1], [@pone.0070301-Magitta1] among 833 T1D cases and 3,623 controls. As shown in [Figure 2](#pone-0070301-g002){ref-type="fig"}, our result indicated that rs12150220 of *NLRP1* gene was significantly associated with T1D risk in the Caucasian and Brazilian populations (the overall OR = 0.71, 95% CI = 0.55--0.92, P = 0.01). Meta-analysis of rs11594656 of *IL2RA* gene among 17,523 T1D cases and 19,909 controls [@pone.0070301-Fichna1], [@pone.0070301-Kawasaki1], [@pone.0070301-Smyth1], [@pone.0070301-Lowe1] indicated that rs11594656 of *IL2RA* gene was significantly associated with T1D risk in the Caucasian and Japanese populations ([Figure 2](#pone-0070301-g002){ref-type="fig"}, the overall OR = 0.86, 95% CI = 0.82--0.91, P\<0.00001). Meta-analysis of rs725613 of *CLEC16A* gene [@pone.0070301-Zoledziewska1], [@pone.0070301-Wu1], [@pone.0070301-Hakonarson1] included 1,803 T1D cases and 3,271 controls. As shown in the [Figure 2](#pone-0070301-g002){ref-type="fig"}, there was significant association between rs725613 of *CLEC16A* gene and T1D in Caucasian and Chinese populations (the overall OR = 0.71, 95% CI = 0.55--0.92, P = 0.01). Meta-analysis of −1131T/C of *APOA5* gene [@pone.0070301-Qiao1], [@pone.0070301-Li1], [@pone.0070301-Zhai1], [@pone.0070301-Talmud1], [@pone.0070301-Yan1] among 795 T2D cases and 3210 controls indicated that −1131T/C of *APOA5* gene was associated with T2D in Chinese and Caucasian populations ([Figure 3](#pone-0070301-g003){ref-type="fig"}, the overall OR = 1.27, 95% CI = 1.03--1.57, P = 0.03). For the rest 6 SNPs, our meta-analyses were unable to find significant associations of them with T1D or T2D.

Discussion {#s4}
==========

In the present study, a comprehensive systematic overview of genetic association studies was performed for the susceptibility of T1D and T2D. We scrutinized all the candidate case-control studies to identify the eligible SNPs with at least three independent datasets. Our meta-analyses of 10 polymorphisms showed significant evidence for 3 T1D-associated SNPs (*NLRP1* rs12150220, *IL2RA* rs11594656, and *CLEC16A* rs725613) and 1 T2D-associated SNP (*APOA5* −1131T/C). Our meta-analyses were unable to find significant associations of the rest 6 SNPs with T1D or T2D. Moreover, power analysis showed that there might be a lack of power for the meta- analysis of *SLC2A10* rs2335491 (1,455 cases and 1,083 controls, 39%) under a moderate risk of diabetes (OR = 1.2). These might partly explain our failure to observe significant results for the meta-analyses of some polymorphisms.

After Bonferroni correction, only the association of SNP rs11594656 with T2D remains significant. However, false discovery rate (FDR) test, a less conservative correction for multiple hypothesis testing, shows that the q values are 5.11E-5 for *IL2RA* rs11594656, 0.051 for *NLRP1* rs12150220, 0.026 for *CLEC16A* rs725613, and 0.051 for *APOA5* −1131T/C. This suggests the robustness of our positive results in the meta-analyses, although we can't exclude a chance of false positive results for *NLRP1* rs12150220, *CLEC16A* rs725613 and *APOA5* −1131T/C. Sensitivity analysis demonstrated there were no significant differences of four significant genetic variants after exclusion, suggesting that the results of our meta-analyses was robust. In addition, we have performed a comprehensive analysis for the Fst values of the involved SNPs. Our results show there are moderate ethnic differences for *ATF6* rs2070150 (Fst = 0.13), although there are minimal heterogeneity among the involved studies from different ethnic groups (I^2^ = 0). And *KLF11A* rs35927125 is monomorphic in Asians, however, its minor allele frequency in Caucasian populations ranges from 8.8--12.2% (Fst = 0.0232). On the contrary, there were little ethnic difference for *CLEC16A* rs725613 and *GNB3* rs5443 (Fst \<0.1), although there exist large heterogeneity in the involved studies (I^2^\>60%). For *CASQ1* rs2275703, the heterogeneity might come from the discrepancies of the samples in the case-control studies.

Pancreatic β-cell inflammation and apoptosis plays a pivotal role in the pathogenesis of T1D [@pone.0070301-Ritvo1]. As a member of the Ced-4 family of apoptosis proteins, *NLRP1* is an important mediator of programmed cell death [@pone.0070301-Dowling1]. *NLRP1* plays a pivotal role in the pathogenesis of some inflammatory diseases [@pone.0070301-Schroder1], [@pone.0070301-Martinon1]. In the present research, we combined three independent datasets and performed a meta-analysis to evaluate the association between *NLRP1* rs12150220 polymorphism and T1D susceptibility. Although large ethnic differences of allele frequency were found for *NLRP1* rs12150220 (T allele frequency: 47--53.1% in Caucasians versus 66.4% in Brazilians), minimal heterogeneity was observed in the meta-analysis of this polymorphism (I^2^ = 0%). Our results support *NLRP1* rs12150220 as a protective genetic factor of T1D and provide hints to clarify the mechanistic role of *NLRP1* gene in the pathogenesis of T1D.

Evidence from both genetic and animal model studies has shown a crucial role of IL-2/IL-2RA in the pathogenesis of T1D [@pone.0070301-Lowe1], [@pone.0070301-Garg1]--[@pone.0070301-Chistiakov1]. IL-2/IL-2RA regulates CD4^+^CD25^+^ regulatory T cells so as to maintain immune homeostasis [@pone.0070301-Chistiakov1]. *IL-2RA* rs12722495 was shown to contribute to the risk of T1D by lowering IL-2 signaling and diminishing the function of CD4^+^CD25^+^ regulatory T cells [@pone.0070301-Garg1]. Interestingly, there is a significant association of *IL-2RA* rs11594656 as a protective factor with the risk of T1D in Polish population [@pone.0070301-Fichna1]. These two SNPs were 24.726 kb away and not in the same linkage disequilibrium block. Expansion of CD4^+^CD25^+^FOXP3^+^ regulatory T cells through maternal insulin treatment was shown to reduce the risk of T1D in children [@pone.0070301-Luopajarvi1]. Increased resistance to CD4^+^CD25hi regulatory T cell-mediated suppression was showed in T1D patients [@pone.0070301-Lawson1]. Our meta-analysis established a significant association between *IL-2RA* rs11594656 polymorphism and T1D, although the influence of rs11594656 polymorphism on the regulation of *IL-2RA* gene remains to be unveiled in the future.

*CLEC16A* gene is located in the major histocompatibility complex class II region (16p13), and it encodes a member of the C-type lectin domain containing family. *CLEC16A* gene variants were associated with multiple autoimmune diseases such as T1D [@pone.0070301-Hakonarson1], [@pone.0070301-Wang2]--[@pone.0070301-Banos1]. *CLEC16A* gene variants were shown to be associated with the alternative splicing event in the *CLEC16A* transcription [@pone.0070301-Mero1]. Our results suggested a significant association between *CLEC16A* rs725613 and T1D among 5,074 samples from Caucasian and Chinese populations (P = 0.01). A significant heterogeneity (I^2^ = 69%) among these ethnic samples warranted a replication in additional populations.

High level of glucose was shown to induce expression of *APOA5* [@pone.0070301-Nowak1], [@pone.0070301-PrunetaDeloche1] that is an efficient regulator of plasma triglycerides (TGs) by enhancing the catabolism of TG-rich lipoproteins [@pone.0070301-Jakel1] and prohibiting the transportation of TGs [@pone.0070301-Garelnabi1]. *APOA5* could probably play a role in the pathogenesis of T2D by regulating the cholesterol homeostasis [@pone.0070301-Talmud1], [@pone.0070301-Jakel1]. *APOA5* gene variants were also reported to be associated with the lipid levels [@pone.0070301-Yan1], [@pone.0070301-Soter1], [@pone.0070301-Esteve1] and the risk of coronary heart disease [@pone.0070301-Bhaskar1], [@pone.0070301-Charriere1] in T2D patients. Since both environmental factors [@pone.0070301-Grarup1], [@pone.0070301-Jiang2] and other genes [@pone.0070301-Hiramatsu1] interact with *APOA5* gene, our significant observation for *APOA5* −1131T/C polymorphism may only partly explain the risk of T2D. Minimal heterogeneity among the involved studies in our meta-analysis (I^2^ = 1%), however, along with previous results [@pone.0070301-Dorfmeister1], [@pone.0070301-Chandak1], in which ethnic differences were observed for the T allele frequency of *APOA5* −1131T/C among the studies in our meta-analysis (68.8--76% in Chinese versus 93.7% in Caucasians).

There are some limitations in the present study. Firstly, publishing bias might exist in this meta-analysis. Case-control studies with a lack of significant results were much harder to be published than those with positive findings. In addition, only publications in English and Chinese were included in the current meta-analyses. All these may distort the results in our meta-analyses. Secondly, some of the involved case-control studies [@pone.0070301-Fichna1]--[@pone.0070301-Hu1], [@pone.0070301-Altinova1], [@pone.0070301-Wu1], [@pone.0070301-Smyth1], [@pone.0070301-Ma1], [@pone.0070301-Tanahashi1], [@pone.0070301-Lowe1]--[@pone.0070301-Zhai1], [@pone.0070301-Chu1], [@pone.0070301-Florez1]--[@pone.0070301-Thameem1], [@pone.0070301-Santiago1], [@pone.0070301-Mohlke1]--[@pone.0070301-Nistico1] didn't provide information on the exclusion of other diseases (such as coronary artery diseases, hypertension, and etc.) during recruitment. Thirdly, the effects of genetic factors on diabetes risk were confounded by other phenotypic parameters such as body mass index. Therefore, case-control studies with better design are warranted to avoid these confounding factors and replicate our findings in future. Fourthly, due to a lack of enough independent datasets, subgroup analysis and meta-regression were not applied to identify differences in effect and sources of heterogeneity. Lastly, our meta-analysis focused on gene loci with at least three independent studies, and this might prevent those gene loci in two large scale case-control studies from being included in the current meta-analysis.

In conclusion, we identify significant associations between 4 SNPs (*NLRP1* rs12150220, *IL2RA* rs11594656, *CLEC16A* rs725613 and *APOA5* −1131T/C) and diabetes. Meta-analysis among 4,456 samples has confirmed that rs12150220 of *NLRP1* gene is a risk factor of T1D in Caucasian and Brazilian populations. Meta-analysis among 37,432 samples has confirmed that rs11594656 of *IL2RA* gene is a risk factor of T1D in Caucasian and Japanese populations. Meta-analysis among 5,074 samples has confirmed that rs725613 of *CLEC16A* gene is a risk factor of T1D in Caucasian and Chinese populations. Another meta-analysis among 4,005 samples indicates that −1131T/C of *APOA5* gene is a risk factor of T1D/T2D in Chinese and Caucasian populations.
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